# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Division 2.2: Introduction

Extent: E+W+S+N.I.

Information on the pharmacological class, mode of action and proposed clinical use of the medicinal product for which a marketing authorisation is requested shall be supplied.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/annex/I/part/I/division/2/division/2.2 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/annex-I/part-I/division-2/division-2.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.